ASN
CERE

Advisory Services Network’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Advisory Services Network’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,058
Closed -$309K – 3378
2021
Q2 		$309K Buy
+12,058
New +$173K 0.01% 1077

Other funds holding CERE

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Advisory Services Network's CERE Position: Q3 2021 in Review

Advisory Services Network sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2021, closing a stake of 12,058 shares — an estimated $309K sold.

Advisory Services Network first reported a position in CERE in Q2 2021 and held it in 1 quarter. The position peaked at $309K in Q2 2021. 94 funds tracked by Wall St. Rank hold CERE as of Q3 2021.

  • Advisory Services Network reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Advisory Services Network sold 12,058 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2021, an estimated $309K.
  • Advisory Services Network first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Advisory Services Network's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $309K in Q2 2021.
  • 94 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.